Skip to main content
HLB Therapeutics Co.,Ltd. logo

HLB Therapeutics Co.,Ltd. — Investor Relations & Filings

Ticker · 115450 ISIN · KR7115450009 KO Manufacturing
Open in API
Filings indexed 444 across all filing types
Latest filing 2021-06-15 Regulatory Filings
Country KR South Korea
Listing KO 115450

About HLB Therapeutics Co.,Ltd.

https://hlbtherapeutics.co.kr/en/

HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the setting of a record date and shareholder register closure for an upcoming Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal regulatory announcement of the administrative steps taken by the company. Given it is a standard regulatory disclosure regarding corporate actions, it fits best under the RNS category.
2021-06-15 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a Korean company (HLB Therapeutics, formerly GtreeBNT) regarding the acquisition of convertible bonds before maturity (early redemption). This type of disclosure relates to the company's capital structure and debt management. Since it specifically details the repurchase/acquisition of its own debt instruments (convertible bonds), it falls under the category of Capital/Financing Update.
2021-06-08 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). It is a formal regulatory filing submitted to the Financial Supervisory Service/Korea Exchange, detailing amendments (정정신고) to the terms of a previously announced convertible bond issuance, such as maturity dates, conversion prices, and payment schedules. This falls under the category of capital and financing updates.
2021-05-31 Korean
불성실공시법인지정예고(공시번복)
Regulatory Filings Classification · 95% confidence The document is a regulatory notice from the Korea Exchange regarding the designation of a company (HLB Therapeutics, formerly GtreeBNT) as an 'unfaithful disclosure corporation' due to a disclosure reversal (cancellation of treasury stock disposal). This is a formal regulatory announcement concerning compliance and potential penalties, which fits the definition of a regulatory filing.
2021-05-27 Korean
[기재정정]불성실공시법인지정예고(공시번복)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KOSDAQ) regarding a 'Notice of Designation as an Unfaithful Disclosure Corporation' (불성실공시법인지정예고). It details a disclosure violation (cancellation of treasury stock disposal) and the potential penalties involved. Since this is a specific regulatory notification regarding compliance and disclosure status that does not fit into financial reporting or corporate action categories, it is classified as a Regulatory Filing (RNS).
2021-05-27 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by HLB Therapeutics (formerly GtreeBNT). It details the contract value, counterparty (Public Procurement Service), and contract terms. Since this is a specific regulatory disclosure of a material business event that does not fit into categories like financial reports, dividends, or governance, it falls under the general regulatory filing category.
2021-05-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.